107 related articles for article (PubMed ID: 35169154)
1. A population study of clinically actionable genetic variation affecting drug response from the Middle East.
Jithesh PV; Abuhaliqa M; Syed N; Ahmed I; El Anbari M; Bastaki K; Sherif S; Umlai UK; Jan Z; Gandhi G; Manickam C; Selvaraj S; George C; Bangarusamy D; Abdel-Latif R; Al-Shafai M; Tatari-Calderone Z; Estivill X; Pirmohamed M;
NPJ Genom Med; 2022 Feb; 7(1):10. PubMed ID: 35169154
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
Nguyen TT; Pearson RA; Mohamed ME; Schladt DP; Berglund D; Rivers Z; Skaar DJ; Wu B; Guan W; van Setten J; Keating BJ; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
J Clin Pharm Ther; 2020 Dec; 45(6):1457-1465. PubMed ID: 32662547
[TBL] [Abstract][Full Text] [Related]
3. Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
Chanfreau-Coffinier C; Hull LE; Lynch JA; DuVall SL; Damrauer SM; Cunningham FE; Voight BF; Matheny ME; Oslin DW; Icardi MS; Tuteja S
JAMA Netw Open; 2019 Jun; 2(6):e195345. PubMed ID: 31173123
[TBL] [Abstract][Full Text] [Related]
4. Phenotype prediction and characterization of 25 pharmacogenes in Thais from whole genome sequencing for clinical implementation.
Mauleekoonphairoj J; Chamnanphon M; Khongphatthanayothin A; Sutjaporn B; Wandee P; Poovorawan Y; Nademanee K; Pongpanich M; Chariyavilaskul P
Sci Rep; 2020 Nov; 10(1):18969. PubMed ID: 33144648
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomic landscape of Indian population using whole genomes.
Sahana S; Bhoyar RC; Sivadas A; Jain A; Imran M; Rophina M; Senthivel V; Kumar Diwakar M; Sharma D; Mishra A; Sivasubbu S; Scaria V
Clin Transl Sci; 2022 Apr; 15(4):866-877. PubMed ID: 35338580
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomic survey of Qatari populations using whole-genome and exome sequences.
Sivadas A; Scaria V
Pharmacogenomics J; 2018 Jul; 18(4):590-600. PubMed ID: 29720721
[TBL] [Abstract][Full Text] [Related]
7. A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
Mizzi C; Dalabira E; Kumuthini J; Dzimiri N; Balogh I; Başak N; Böhm R; Borg J; Borgiani P; Bozina N; Bruckmueller H; Burzynska B; Carracedo A; Cascorbi I; Deltas C; Dolzan V; Fenech A; Grech G; Kasiulevicius V; Kádaši Ľ; Kučinskas V; Khusnutdinova E; Loukas YL; Macek M; Makukh H; Mathijssen R; Mitropoulos K; Mitropoulou C; Novelli G; Papantoni I; Pavlovic S; Saglio G; Setric J; Stojiljkovic M; Stubbs AP; Squassina A; Torres M; Turnovec M; van Schaik RH; Voskarides K; Wakil SM; Werk A; Del Zompo M; Zukic B; Katsila T; Lee MT; Motsinger-Rief A; Mc Leod HL; van der Spek PJ; Patrinos GP
PLoS One; 2016; 11(9):e0162866. PubMed ID: 27636550
[TBL] [Abstract][Full Text] [Related]
8. Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations.
Al-Mahayri ZN; Patrinos GP; Wattanapokayakit S; Iemwimangsa N; Fukunaga K; Mushiroda T; Chantratita W; Ali BR
Sci Rep; 2020 Dec; 10(1):21310. PubMed ID: 33277594
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic profile of actionable molecular variants related to drugs commonly used in anesthesia: WES analysis reveals new mutations.
Parada-Márquez JF; Maldonado-Rodriguez ND; Triana-Fonseca P; Contreras-Bravo NC; Calderón-Ospina CA; Restrepo CM; Morel A; Ortega-Recalde OJ; Silgado-Guzmán DF; Angulo-Aguado M; Fonseca-Mendoza DJ
Front Pharmacol; 2023; 14():1047854. PubMed ID: 37021041
[No Abstract] [Full Text] [Related]
10. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
[TBL] [Abstract][Full Text] [Related]
11. Primary Care Prescription Drug Use and Related Actionable Drug-Gene Interactions in the Danish Population.
Lunenburg CATC; Hauser AS; Ishtiak-Ahmed K; Gasse C
Clin Transl Sci; 2020 Jul; 13(4):798-806. PubMed ID: 32166845
[TBL] [Abstract][Full Text] [Related]
12. Use of Pharmacogenetic Drugs by the Dutch Population.
Alshabeeb MA; Deneer VHM; Khan A; Asselbergs FW
Front Genet; 2019; 10():567. PubMed ID: 31312209
[TBL] [Abstract][Full Text] [Related]
13. Copy number variations in the genome of the Qatari population.
Fakhro KA; Yousri NA; Rodriguez-Flores JL; Robay A; Staudt MR; Agosto-Perez F; Salit J; Malek JA; Suhre K; Jayyousi A; Zirie M; Stadler D; Mezey JG; Crystal RG
BMC Genomics; 2015 Oct; 16():834. PubMed ID: 26490036
[TBL] [Abstract][Full Text] [Related]
14. Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico.
Gonzalez-Covarrubias V; Morales-Franco M; Cruz-Correa OF; Martínez-Hernández A; García-Ortíz H; Barajas-Olmos F; Genis-Mendoza AD; Martínez-Magaña JJ; Nicolini H; Orozco L; Soberón X
Front Pharmacol; 2019; 10():1169. PubMed ID: 31649539
[TBL] [Abstract][Full Text] [Related]
15. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
[TBL] [Abstract][Full Text] [Related]
16. Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Wellmann R; Borden BA; Danahey K; Nanda R; Polite BN; Stadler WM; Ratain MJ; O'Donnell PH
Cancer; 2018 Jul; 124(14):3052-3065. PubMed ID: 29742281
[TBL] [Abstract][Full Text] [Related]
17. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.
Van Driest SL; Shi Y; Bowton EA; Schildcrout JS; Peterson JF; Pulley J; Denny JC; Roden DM
Clin Pharmacol Ther; 2014 Apr; 95(4):423-31. PubMed ID: 24253661
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.
Li D; Peng L; Xing S; He C; Jin T
BMC Genom Data; 2021 Nov; 22(1):51. PubMed ID: 34798807
[TBL] [Abstract][Full Text] [Related]
19. Mapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented Population.
Samarasinghe SR; Lee SB; Corpas M; Fatumo S; Guchelaar HJ; Nagaraj SH
Clin Pharmacol Ther; 2024 Jun; ():. PubMed ID: 38837390
[TBL] [Abstract][Full Text] [Related]
20. Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population.
Goljan E; Abouelhoda M; ElKalioby MM; Jabaan A; Alghithi N; Meyer BF; Monies D
PLoS One; 2022; 17(1):e0263137. PubMed ID: 35089958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
